Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment

Published:2022-08-31 Issue:12 Volume:24 Page:2297-2308
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Aroda Vanita R.¹^ORCID,Eckel Robert H.²

Affiliation:

1. Division of Endocrinology, Diabetes, and Hypertension Brigham and Women's Hospital Boston Massachusetts

2. Division of Endocrinology, Metabolism, and Diabetes, and the Division of Cardiology University of Colorado School of Medicine Aurora Colorado

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14830

Reference126 articles.

1. Diabetes and Cardiovascular Disease

2. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

3. Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care

4. Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes

5. Definition of Metabolic Syndrome

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between the Canadian active living environments index and glucose metabolism in a Canadian national population study;Environmental Research;2024-10

2. Diabetes Management Based on the Phenotype and Stage of the Disease: An Expert Proposal from the AGORA Diabetes Collaborative Group;Journal of Clinical Medicine;2024-08-16

3. A comprehensive in-vitro/in-vivo screening toolbox for the elucidation of glucose homeostasis modulating properties of plant extracts (from roots) and its bioactives;Frontiers in Pharmacology;2024-06-26

4. The impact of slowly digestible and resistant starch on glucose homeostasis and insulin resistance;Current Opinion in Clinical Nutrition & Metabolic Care;2024-06-06

5. Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trial;The Lancet Regional Health - Western Pacific;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3